Use of inhibitors of progesterone receptor for treating cancer

Details for Australian Patent Application No. 2002215958 (hide)

Owner Schering AG

Inventors Fuhrmann, Ulrike; Lichtner, Rosemarie

Agent Davies Collison Cave

Pub. Number AU-B-2002215958

PCT Pub. Number WO02/32429

Priority 100 51 609.2 18.10.00 DE; 60/241,010 18.10.00 US

Filing date 17 October 2001

Wipo publication date 29 April 2002

Acceptance publication date 17 August 2006

International Classifications

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Event Publications

17 August 2006 Application Accepted

  Published as AU-B-2002215958

2 November 2006 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 16 Oct 2006. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

14 December 2006 Standard Patent Sealed

15 March 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 16 Oct 2006

13 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002215959

2002215957-Method of producing carboxylic acid salts